We are monitoring the impact of COVID-19 on Europe Medical Cannabis Market Get in touch with us for detailed analysis Know More
Pulished Date July, 2020
ID: 9876
Share on
Share on

Europe Medical Cannabis Market Research Report - Segmented By Species, Derivatives, Application, Route of Administration & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of EU) – Industry Size, Share, Trends & Growth Forecast (2020 to 2025)

Pulished: July, 2020
ID: 9876
Pages: 100

Europe Medical Cannabis Market Size & Growth (2020 to 2025)

The Size of the Medical Cannabis Market in Europe is projected to grow at a decent rate of CAGR (%) during the forecast period 2020 – 2025.

Medical Cannabis is used to treat chronic conditions, such as Cancer, Arthritis, and Neurological disorders, including anxiety, depression, Parkinson's, Epilepsy, and Alzheimer's disease. There have been a dozen mergers and acquisitions or private placements focusing on medical cannabis in Europe. According to the cannabis media, legal marijuana in the medical market creates multiple jobs and opportunities. The prescribed physician categorizes the usage of marijuana; the government controls and regulates marijuana medicine products' distribution. The researchers have revealed that the human body naturally produces its Cannabinoids and uses them to regulate homeostasis.

MARKET DRIVERS

Cannabis is gaining momentum around Europe with the legalization of its product usage. The market is primarily driven by increasing recognition of medical benefits and therapeutic applications of Marijuana. Marijuana is being used to treat chronic diseases such as cancer and neurological conditions, anxiety, and depression, which is estimated to increase the market growth. Moreover, marijuana products have been legalized in European countries for medical usage, and it is expected to provide various jobs and opportunities in the developed countries. The legalization of Marijuana has led to an increase in the demand for Marijuana fields; the cultivators and manufacturers focus on producing and manufacturing more marijuana products, leading to market growth. Cannabis consumer product companies and retailers are ensuring to meet the needs of the cannabis consumers. Besides, the increasing variety of products, ease of use, product safety, and growing applications of cannabis in various medical conditions are expected to drive the market growth.

MARKET RESTRAINTS

The strict regulations on the structure for the usage of cannabis are restraining the market growth of the Medical cannabis market. Companies offering cannabis and cannabis-infused products must comply with different guidelines across Europe.

IMPACT OF COVID-19 ON EUROPEAN MEDICAL CANNABIS MARKET

Pioneer Cannabis medical product distributor had announced €12 M's capital by US base traditional investor Steve Wiggins, which increased the amount invested in the company to € 27M. Still, the deal was canceled due to the sudden announcement of a lockdown in Germany. Since January 2020, it was seen that the overall cannabis stock went down by 30%-40% and by the end of March, it was again noticed that the supplies were recovering with incumbents such as Canopy growth as per pre-COVID-19. After the unlock of lack of lockdown, both medical and recreational users are more likely to increase or maintain medical cannabis products, which leads to market growth. However, despite the negative impact at the earlier period, the market is expected to increase its growth by 2021.

This research report is segmented and sub-segmented into the following categories:

  • By Species: Indica, Sativa, Hybrid.
  • By Derivatives: Cannabidiol (CBD), Tetrahydrocannabinol (THC), Others.
  • By Application: Cancer, Arthritis, Epilepsy, and Migraine.
  • By End User:  Pharmaceutical Industry, Research, and Development Centers, Others.
  • By Route of Administration: Oral Solutions and Capsules, Smoking, Vaporizers, Topicals, Others.
  • By Country:  UK, France, Spain, Germany, Italy,  Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe

Geographically, European medical cannabis was the second-largest worldwide in 2019 and predicted to grow at a robust CAGR between 2020 to 2025. In Europe, 80 percent of deals are concerned with Germany-based companies that are actively involved in distributing medical cannabis products within the country. There has been significant growth in the European cannabis market over the years.

Germany Medical Cannabis Market

The German Medical Cannabis market is predicted to play the leading role in the European market during the forecast period. In 2017, Germany made some amendments to its regulations on the use of cannabis products. It is observed that the patient population has been receiving medical cannabis products, as per the records, 2019, 1,000 people to more than 60,000 has increased the usage of medical cannabis products.

UK Medical Cannabis Market

Next in line is the UK and the market is estimated to have a progressive CAGR between 2020 to 2025. The UK has been witnessed as the largest producer and the exporter of legal cannabis for medical and research applications. Well established companies are introducing advanced products in the market. Therefore, it is expected that the UK's cannabis market will be enhanced with the legalization of cannabis in the European region. European cannabis accountable Millers & Miller's chemicals Ltd. formed Astral Health, a new end-to-end platform in the United Kingdom to approve medical cannabis products.

Italy Medical Cannabis Market

In Italy, medical cannabis was legalized in 2013. It held Europe's second-largest producer of medical cannabis market during the previous year. It announced its intention to triple the domestic production to meet the demands.

France Medical Cannabis Market

France legalizes cannabis for medical usage because of its beneficial factors to cancer patients. In 2017, Spain had legalized recreational cannabis in the cannabis club to ensure the benefits provided by the cannabis to the cancer patient population in the country.      

Key Companies dominating the European Medical Cannabis Market Profiled in the Report are BOL Pharma, Tilray, Medreleaf Corporation, Aurora Cannabis, Inc., Canopy Growth Corporation, Insys Therapeutics, Inc., Aphria, Inc., MGC Pharmaceuticals Limited, GW Pharmaceuticals, plc.

  1. Introduction
    1. Europe Medical Cannabis Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
        1. Secondary Research
        2. Primary Research
        3. Econometric Modelling
        4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Europe Medical Cannabis Market Drivers
    2. Europe Medical Cannabis Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Europe Medical Cannabis Market Segmentation
    1. By Species
      1. Indica
      2. Satiiva
      3. Hybrid
      4. Y-o-Y Growth Analysis, By Species
      5. Europe Medical Cannabis Market Attractiveness Analysis, By Species
      6. Europe Medical Cannabis Market Share Analysis, By Species
    2. By Derivatives
      1. Cannabidiol (CBD)
      2. Tetrahydrocannabinol (THC)
      3. Others
      4. Y-o-Y Growth Analysis, By Derivatives
      5. Europe Medical Cannabis Market Attractiveness Analysis, By Derivatives
      6. Europe Medical Cannabis Market Share Analysis, By Derivatives
    3. By Application
      1. Cancer
      2. Arthritis
      3. Epilepsy
      4. Migraine
      5. Y-o-Y Growth Analysis, By Application
      6. Europe Medical Cannabis Market Attractiveness Analysis, By Application
      7. Europe Medical Cannabis Market Share Analysis, By Application
    4. By End User
      1. Pharmaceutical Industry
      2. Research and Development Centers
      3. Others
      4. Y-o-Y Growth Analysis, By End User
      5. Europe Medical Cannabis Market Attractiveness Analysis, By End User
      6. Europe Medical Cannabis Market Share Analysis, By End User
    5. By Route of Administration
      1. Oral Solutions and Capsules
      2. Smoking
      3. Vaporizers
      4. Topicals
      5. Y-o-Y Growth Analysis, By Route of Administration
      6. Europe Medical Cannabis Market Attractiveness Analysis, Route of Administration
      7. Europe Medical Cannabis Market Share Analysis, Route of Administration
  6. Geographical Analysis
    1. Introduction    
      1. Regional Trends   
      2. Impact Analysis    
      3. Y-o-Y Growth Analysis        
        1. By Geographical Area
        2. By Species
        3. By Derivatives
        4. By Application
        5. By End-User
        6. By Route of Administration
      4. Europe Medical Cannabis Market Attractiveness Analysis 
        1. By Geographical Area
        2. By Species
        3. By Derivatives
        4. By Application
        5. By End-User
        6. By Route of Administration
      5.      Europe Medical Cannabis Market Share Analysis              
        1. By Geographical Area
        2. By Species
        3. By Derivatives
        4. By Application
        5. By End-User
        6. By Route of Administration
    2. Europe
      1. Introduction
      2. UK
      3. France
      4. Spain
      5. Germany
      6. Italy
  7.  Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Europe Medical Cannabis Market Leaders' Analysis
    1. BOL Pharma
      1. Overview
      2. Product Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. Tilray
    3. Medreleaf Corporation
    4. Aurora Cannabis, Inc
    5. Canopy Growth Corporation
    6. Insys Therapeutics, Inc
    7. Aphria, Inc
    8. MGC Pharmaceuticals Limited
    9. GW Pharmaceuticals, plc
  9. Competitive Landscape
    1. Europe Medical Cannabis Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, Collaborations and Joint Ventures
    4. New Product Launches
  10. Europe Medical Cannabis Market Outlook and Investment Opportunities
  11. Appendix
    1. List of Tables
    2. List of Figures  
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
  • Segment-level analysis in terms of Type, application, end user and region along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development.
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions.
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
  1. Europe Medical Cannabis Market Market By Species, From 2020 to 2025 ( USD Billion )
  2. Europe Indica Market By Region, From 2020 to 2025 ( USD Billion )
  3. Europe Sativa Market By Region, From 2020 to 2025 ( USD Billion )
  4. Europe Hybrid Market By Region, From 2020 to 2025 ( USD Billion )
  5. Europe Medical Cannabis Market Market By Derivatives, From 2020 to 2025 ( USD Billion )
  6. Europe Cannabidiol (CBD) Market By Region, From 2020 to 2025 ( USD Billion )
  7. Europe Tetrahydrocannabinol (THC) Market By Region, From 2020 to 2025 ( USD Billion )
  8. Europe Others Market By Region, From 2020 to 2025 ( USD Billion )
  9. Europe Medical Cannabis Market Market By Application, From 2020 to 2025 ( USD Billion )
  10. Europe Cancer Market By Region, From 2020 to 2025 ( USD Billion )
  11. Europe Arthritis Market By Region, From 2020 to 2025 ( USD Billion )
  12. Europe Epilespy Market By Region, From 2020 to 2025 ( USD Billion )
  13. Europe Migraine Market By Region, From 2020 to 2025 ( USD Billion )
  14. Europe Medical Cannabis Market Market By End-User, From 2020 to 2025 ( USD Billion )
  15. Europe Pharmaceutical Industry Market By Region, From 2020 to 2025 ( USD Billion )
  16. Europe Research and Development Centers Market By Region, From 2020 to 2025 ( USD Billion )
  17. Europe others Market By Region, From 2020 to 2025 ( USD Billion )
  18. Europe Medical Cannabis Market Market By Route of Administration, From 2020 to 2025 ( USD Billion )
  19. Europe Oral Solutions and Capsules Market By Region, From 2020 to 2025 ( USD Billion )
  20. Europe Smoking Market By Region, From 2020 to 2025 ( USD Billion )
  21. Europe Vaporizers Market By Region, From 2020 to 2025 ( USD Billion )
  22. Europe Topicals Market By Region, From 2020 to 2025 ( USD Billion )
  23. Europe others Market By Region, From 2020 to 2025 ( USD Billion )
  24. U.K. Medical Cannabis Market Market By Species, From 2020 to 2025 ( USD Billion )
  25. U.K. Medical Cannabis Market Market By Derivatives, From 2020 to 2025 ( USD Billion )
  26. U.K. Medical Cannabis Market Market By Application, From 2020 to 2025 ( USD Billion )
  27. U.K. Medical Cannabis Market Market By End-User, From 2020 to 2025 ( USD Billion )
  28. U.K. Medical Cannabis Market Market By Route of Administration, From 2020 to 2025 ( USD Billion )
  29. Germany Medical Cannabis Market Market By Species, From 2020 to 2025 ( USD Billion )
  30. Germany Medical Cannabis Market Market By Derivatives, From 2020 to 2025 ( USD Billion )
  31. Germany Medical Cannabis Market Market By Application, From 2020 to 2025 ( USD Billion )
  32. Germany Medical Cannabis Market Market By End-User, From 2020 to 2025 ( USD Billion )
  33. Germany Medical Cannabis Market Market By Route of Administration, From 2020 to 2025 ( USD Billion )
  34. France Medical Cannabis Market Market By Species, From 2020 to 2025 ( USD Billion )
  35. France Medical Cannabis Market Market By Derivatives, From 2020 to 2025 ( USD Billion )
  36. France Medical Cannabis Market Market By Application, From 2020 to 2025 ( USD Billion )
  37. France Medical Cannabis Market Market By End-User, From 2020 to 2025 ( USD Billion )
  38. France Medical Cannabis Market Market By Route of Administration, From 2020 to 2025 ( USD Billion )
  39. Italy Medical Cannabis Market Market By Species, From 2020 to 2025 ( USD Billion )
  40. Italy Medical Cannabis Market Market By Derivatives, From 2020 to 2025 ( USD Billion )
  41. Italy Medical Cannabis Market Market By Application, From 2020 to 2025 ( USD Billion )
  42. Italy Medical Cannabis Market Market By End-User, From 2020 to 2025 ( USD Billion )
  43. Italy Medical Cannabis Market Market By Route of Administration, From 2020 to 2025 ( USD Billion )
  44. Spain Medical Cannabis Market Market By Species, From 2020 to 2025 ( USD Billion )
  45. Spain Medical Cannabis Market Market By Derivatives, From 2020 to 2025 ( USD Billion )
  46. Spain Medical Cannabis Market Market By Application, From 2020 to 2025 ( USD Billion )
  47. Spain Medical Cannabis Market Market By End-User, From 2020 to 2025 ( USD Billion )
  48. Spain Medical Cannabis Market Market By Route of Administration, From 2020 to 2025 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample